Nanjing Pharmaceutical Company Overview
- Year Founded
-
1951
- Status
-
Public
- Employees
-
4,697
- Stock Symbol
-
600713
- Investments
-
3
- Share Price
-
$0.79
- (As of Thursday Closing)
Nanjing Pharmaceutical Company General Information
Description
Nanjing Pharmaceutical Group Co Ltd engages in pharmaceutical distribution across China, including chain drug stores, delivery services, supply chain management, and logistics. The company is also engaged in the leasing and operation of Class III medical devices, pharmaceutical wholesale and retail, and the import and export of drugs.
Contact Information
Website
www.guangyuyuan.comCorporate Office
- Number 486 Zhongshan East Road
- Nanjing, Jiangsu 210002
- China
Corporate Office
- Number 486 Zhongshan East Road
- Nanjing, Jiangsu 210002
- China
Nanjing Pharmaceutical Company Stock Performance
As of 12-Nov-2026, Nanjing Pharmaceutical Company’s stock price is $0.79. Its current market cap is $1.03B with 1.31B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.79 | $0.78 | $0.70 - $0.97 | $1.03B | 1.31B | 11.8M | $0.07 |
Nanjing Pharmaceutical Company Financials Summary
As of 30-Sep-2026, Nanjing Pharmaceutical Company has a trailing 12-month revenue of $8.05B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,128,449 | 2,107,230 | 2,227,525 | 1,990,036 |
| Revenue | 8,054,198 | 7,643,003 | 7,483,308 | 7,574,639 |
| EBITDA | 217,312 | 239,215 | 220,826 | 228,530 |
| Net Income | 92,574 | 86,887 | 79,525 | 81,673 |
| Total Assets | 5,767,514 | 4,492,176 | 4,201,809 | 4,007,876 |
| Total Debt | 1,385,427 | 834,196 | 1,161,693 | 888,728 |
Nanjing Pharmaceutical Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nanjing Pharmaceutical Company Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nanjing Pharmaceutical Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nanjing Pharmaceutical Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nanjing Pharmaceutical Company Investments & Acquisitions (3)
Nanjing Pharmaceutical Company’s most recent deal was a Merger/Acquisition with Xuzhou Enhua for . The deal was made on 11-Dec-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Xuzhou Enhua | 11-Dec-2019 | Merger/Acquisition | Distributors (Healthcare) | ||
| Nanjing Medicine Nantong Kambridge Company | 25-Jul-2017 | Secondary Transaction - Private | Pharmaceuticals | ||
| Fujian Southeast Pharmaceutical | Merger/Acquisition | Pharmaceuticals |
Nanjing Pharmaceutical Company ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
Nanjing Pharmaceutical Company Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Heling Pharmaceutical Service | Nanjing, China | 2011 | |
| Xuzhou Enhua | Xuzhou, China | 1988 |
Nanjing Pharmaceutical Company FAQs
-
When was Nanjing Pharmaceutical Company founded?
Nanjing Pharmaceutical Company was founded in 1951.
-
Where is Nanjing Pharmaceutical Company headquartered?
Nanjing Pharmaceutical Company is headquartered in Nanjing, China.
-
What is the size of Nanjing Pharmaceutical Company?
Nanjing Pharmaceutical Company has 4,697 total employees.
-
What industry is Nanjing Pharmaceutical Company in?
Nanjing Pharmaceutical Company’s primary industry is Distributors (Healthcare).
-
Is Nanjing Pharmaceutical Company a private or public company?
Nanjing Pharmaceutical Company is a Public company.
-
What is Nanjing Pharmaceutical Company’s stock symbol?
The ticker symbol for Nanjing Pharmaceutical Company is 600713.
-
What is the current stock price of Nanjing Pharmaceutical Company?
As of 12-Nov-2026 the stock price of Nanjing Pharmaceutical Company is $0.79.
-
What is the current market cap of Nanjing Pharmaceutical Company?
The current market capitalization of Nanjing Pharmaceutical Company is $1.03B.
-
What is Nanjing Pharmaceutical Company’s current revenue?
The trailing twelve month revenue for Nanjing Pharmaceutical Company is $8.05B.
-
What is Nanjing Pharmaceutical Company’s annual earnings per share (EPS)?
Nanjing Pharmaceutical Company’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
